Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm

Clin Kidney J. 2020 Sep 24;13(5):903-905. doi: 10.1093/ckj/sfaa193. eCollection 2020 Oct.

¹ Renal Physiopathology Laboratory, Department of Nephrology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)-Hospital General Universitario Gregorio Marañón, Madrid, Spain.
² Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.
³ Department of Physiology, School of Medicine, Universidad Complutense, Madrid, Spain.

No abstract available